Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States ...
Cencora, Inc. (NYSE: COR) is a global pharmaceutical solutions company headquartered in Conshohocken, Pennsylvania. Founded in 1871, it has a long legacy in healthcare distribution and was formerly known as AmerisourceBergen Corporation before rebranding to Cencora in August 2023. The company operates through two main segments: U.S. Healthcare Solutions and International Healthcare Solutions. In the U.S., Cencora distributes a wide range of pharmaceutical products including generic and injectable medications, over-the-counter health products, and home healthcare equipment to a diverse customer base such as acute care hospitals, health systems, retail and mail-order pharmacies, long-term care facilities, and medical clinics. It also handles specialized products like plasma, blood derivatives, and vaccines. Beyond distribution, Cencora offers comprehensive services including pharmacy management, staffing solutions, strategic consulting, supply management software, packaging services, and support for clinical trials and commercialization. For manufacturers, it provides data analytics and outcomes research. The company also serves the animal health market with pharmaceuticals, vaccines, and diagnostics. Internationally, Cencora focuses on pharmaceutical wholesale, logistics, and commercialization support. As of the latest data, Cencora employs approximately 47,000 people and has a market capitalization of around $62.7 billion. The company's financial metrics show a gross profit margin of 3.7%, an operating margin of 1.3%, and a net profit margin of 0.8%. Cencora has a strong focus on innovation and recently announced a $1 billion investment in its U.S. distribution network through 2030. Under the leadership of CEO Robert Mauch, who has over 30 years of experience in pharmaceutical care, the company is committed to improving global health outcomes for people and animals. Cencora's business model leverages its scale and expertise to provide efficient and reliable pharmaceutical supply chain solutions, making it a key player in the healthcare industry.
